HBW Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
HBW Advisory Services's PFE Position: Q2 2026 in Review
HBW Advisory Services reduced its Pfizer (PFE) stake by 4.4% in Q2 2026, selling an estimated $10.5K and leaving 8,688 shares worth $209K. The position accounts for 0.02% of the portfolio, ranked #444.
HBW Advisory Services first reported a position in PFE in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.13M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- HBW Advisory Services held 8,688 shares of Pfizer worth $209K as of Q2 2026.
- HBW Advisory Services sold 401 Pfizer shares in Q2 2026, an estimated $10.5K.
- Pfizer made up 0.02% of HBW Advisory Services's portfolio in Q2 2026, its #444 holding.
- HBW Advisory Services first reported a position in Pfizer in Q3 2020 and has held it in 21 quarters since.
- HBW Advisory Services's Pfizer position peaked at $1.13M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.